Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer

This study has been completed.
Pomeranian Medical University Szczecin
Information provided by (Responsible Party):
Bartosz Dąbek, West Pomeranian Cancer Center Identifier:
First received: February 15, 2014
Last updated: December 7, 2016
Last verified: December 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2016
  Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)